Literature DB >> 27886901

Itch in Atopic Dermatitis.

Makiko Kido-Nakahara1, Masutaka Furue2, Dugarmaa Ulzii2, Takeshi Nakahara3.   

Abstract

Chronic itch in inflammatory skin diseases, such as atopic dermatitis, markedly diminishes the quality of life of affected individuals. Comprehensive progress has been made in understanding itch signaling and associated mediators in the skin, dorsal root ganglia, spinal cord, and central nervous system, which may amplify or suppress atopic itch. Conventional therapies for atopic dermatitis are capable of reducing atopic itch; however, most patients are not satisfied with the antipruritic capacity of conventional treatments. Exploring itch pathways and mechanisms may lead to novel therapeutic approaches for atopic itch. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atopic dermatitis; Hypersensitivity of pruritus; New therapy; Pruritogen; Pruritus

Mesh:

Substances:

Year:  2016        PMID: 27886901     DOI: 10.1016/j.iac.2016.08.007

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  10 in total

Review 1.  "Inflammatory skin march" in atopic dermatitis and psoriasis.

Authors:  Masutaka Furue; Takafumi Kadono
Journal:  Inflamm Res       Date:  2017-06-15       Impact factor: 4.575

2.  Pain in Atopic Dermatitis: An Online Population-based Survey.

Authors:  Flavien Huet; Jason Shourick; Sophie Séité; Charles Taïeb; Laurent Misery
Journal:  Acta Derm Venereol       Date:  2020-07-02       Impact factor: 3.875

Review 3.  The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus.

Authors:  Pawinee Rerknimitr; Atsushi Otsuka; Chisa Nakashima; Kenji Kabashima
Journal:  Inflamm Regen       Date:  2017-06-05

4.  Brain allopregnanolone induces marked scratching behaviour in diet-induced atopic dermatitis mouse model.

Authors:  Masanori Fujii; Sayaka Ohgami; Erika Asano; Takanori Nakayama; Takahiro Toda; Takeshi Nabe; Susumu Ohya
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

5.  Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial.

Authors:  Emma Guttman-Yassky; Andrew Blauvelt; Lawrence F Eichenfield; Amy S Paller; April W Armstrong; Janice Drew; Ramanan Gopalan; Eric L Simpson
Journal:  JAMA Dermatol       Date:  2020-04-01       Impact factor: 10.282

Review 6.  Pruritus in pediatric patients with atopic dermatitis: a multidisciplinary approach - summary document from an Italian expert group.

Authors:  May El Hachem; Giuseppe Di Mauro; Roberta Rotunno; Simona Giancristoforo; Cristiana De Ranieri; Carla Maria Carlevaris; Maria Carmen Verga; Iride Dello Iacono
Journal:  Ital J Pediatr       Date:  2020-01-30       Impact factor: 2.638

7.  Increased Prevalence of Face Mask-Induced Itch in Health Care Workers.

Authors:  Piotr K Krajewski; Łukasz Matusiak; Marta Szepietowska; Rafał Białynicki-Birula; Jacek C Szepietowski
Journal:  Biology (Basel)       Date:  2020-12-07

Review 8.  Interleukin-31 and Pruritic Skin.

Authors:  Masutaka Furue; Mihoko Furue
Journal:  J Clin Med       Date:  2021-04-28       Impact factor: 4.241

9.  Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients.

Authors:  Luca Mastorino; François Rosset; Federica Gelato; Michela Ortoncelli; Giovanni Cavaliere; Pietro Quaglino; Simone Ribero
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-17

Review 10.  Role of Epithelium-Derived Cytokines in Atopic Dermatitis and Psoriasis: Evidence and Therapeutic Perspectives.

Authors:  Francesco Borgia; Paolo Custurone; Lucia Peterle; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Biomolecules       Date:  2021-12-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.